-
1.Antibodies against human interleukin-13 and pharmaceutical compositions thereof 失效
标题翻译: 针对人白细胞介素-13的抗体及其药物组合物公开(公告)号:US07615213B2
公开(公告)日:2009-11-10
申请号:US11149309
申请日:2005-06-09
申请人: Marion T. Kasaian , Lioudmila Tchistiakova , Geertruida M. Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
发明人: Marion T. Kasaian , Lioudmila Tchistiakova , Geertruida M. Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
IPC分类号: A61K39/395
CPC分类号: C07K16/244 , A61K2039/505 , C07K2299/00 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92
摘要: This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
摘要翻译: 本申请涉及结合白细胞介素-13(IL-13)特别是人IL-13的抗体,例如人源化抗体及其抗原结合片段,以及它们在调节由IL-13介导的免疫应答中的用途 。 本文公开的抗体可用于诊断,预防和/或治疗受试者,例如人类患者,一种或多种IL-13相关疾病,例如呼吸系统疾病(例如哮喘); 特应性疾病(如过敏性鼻炎); 皮肤的炎症和/或自身免疫病症(例如特应性皮炎)和胃肠器官(例如炎性肠病(IBD))以及纤维化和癌性疾病。
-
公开(公告)号:US20100129360A1
公开(公告)日:2010-05-27
申请号:US12575896
申请日:2009-10-08
申请人: Marion T. Kasaian , Lioudmila Gennadievna Tchistiakova , Geertruida Machteld Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
发明人: Marion T. Kasaian , Lioudmila Gennadievna Tchistiakova , Geertruida Machteld Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
IPC分类号: A61K39/395 , C07K16/24 , C07K16/18 , C07H21/00 , C12N5/10 , C12P21/00 , G01N33/543 , A61P37/02
CPC分类号: C07K16/244 , A61K2039/505 , C07K2299/00 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92
摘要: This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
摘要翻译: 本申请涉及结合白细胞介素-13(IL-13)特别是人IL-13的抗体,例如人源化抗体及其抗原结合片段及其在调节由IL-13介导的免疫应答中的用途 。 本文公开的抗体可用于诊断,预防和/或治疗受试者,例如人类患者,一种或多种IL-13相关疾病,例如呼吸系统疾病(例如哮喘); 特应性疾病(如过敏性鼻炎); 皮肤的炎症和/或自身免疫病症(例如特应性皮炎)和胃肠器官(例如炎性肠病(IBD))以及纤维化和癌性疾病。
-
公开(公告)号:US08221752B2
公开(公告)日:2012-07-17
申请号:US12575896
申请日:2009-10-08
申请人: Marion T. Kasaian , Lioudmila Gennadievna Tchistiakova , Geertruida Machteld Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
发明人: Marion T. Kasaian , Lioudmila Gennadievna Tchistiakova , Geertruida Machteld Veldman , Kimberly Ann Marquette , Xiang-Yang Tan , Debra D. Donaldson , Laura Long Lin , Tania Shane , Amy Sze Pui Tam , Eric Feyfant , Nancy L. Wood , Lori J. Fitz , Angela M. Widom , Kevin D. Parris , Samuel J. Goldman , Jose W. Saldanha
IPC分类号: A61K39/395
CPC分类号: C07K16/244 , A61K2039/505 , C07K2299/00 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92
摘要: This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
摘要翻译: 本申请涉及结合白介素13(IL-13),特别是人IL-13的抗体,例如人源化抗体及其抗原结合片段及其在调节由IL-13介导的免疫应答中的用途 。 本文公开的抗体可用于诊断,预防和/或治疗受试者,例如人类患者,一种或多种IL-13相关疾病,例如呼吸系统疾病(例如哮喘); 特应性疾病(如过敏性鼻炎); 皮肤的炎症和/或自身免疫病症(例如特应性皮炎)和胃肠器官(例如炎性肠病(IBD))以及纤维化和癌性疾病。
-
公开(公告)号:US20060063228A1
公开(公告)日:2006-03-23
申请号:US11149309
申请日:2005-06-09
申请人: Marion Kasaian , Lioudmila Tchistiakova , Geertruida Veldman , Kimberly Marquette , Xiang-Yang Tan , Debra Donaldson , Laura Lin , Tania Shane , Amy Tam , Eric Feyfant , Nancy Wood , Lori Fitz , Angela Widom , Kevin Parris , Samuel Goldman , Jose Saldanha
发明人: Marion Kasaian , Lioudmila Tchistiakova , Geertruida Veldman , Kimberly Marquette , Xiang-Yang Tan , Debra Donaldson , Laura Lin , Tania Shane , Amy Tam , Eric Feyfant , Nancy Wood , Lori Fitz , Angela Widom , Kevin Parris , Samuel Goldman , Jose Saldanha
CPC分类号: C07K16/244 , A61K2039/505 , C07K2299/00 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92
摘要: This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
摘要翻译: 本申请涉及结合白细胞介素-13(IL-13)特别是人IL-13的抗体,例如人源化抗体及其抗原结合片段及其在调节由IL-13介导的免疫应答中的用途 。 本文公开的抗体可用于诊断,预防和/或治疗受试者,例如人类患者,一种或多种IL-13相关疾病,例如呼吸系统疾病(例如哮喘); 特应性疾病(如过敏性鼻炎); 皮肤的炎症和/或自身免疫病症(例如特应性皮炎)和胃肠器官(例如炎性肠病(IBD))以及纤维化和癌性疾病。
-
公开(公告)号:US07553873B2
公开(公告)日:2009-06-30
申请号:US11484005
申请日:2006-07-11
申请人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
发明人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
IPC分类号: A61K31/166 , A61K31/192 , C07C63/06 , C07C237/28
CPC分类号: C07D213/82 , C07B2200/07 , C07C231/16 , C07C233/83 , C07C235/84 , C07C237/22 , C07C237/42 , C07C259/06 , C07C323/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2603/18 , C07C2603/74 , C07D213/38 , C07D239/26 , C07D239/42 , C07D277/30 , C07D307/52 , C07D307/68 , C07D307/79 , C07D307/85 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D333/38 , C07D409/04
摘要: The present invention relates to modulators of metalloproteinase activity.
摘要翻译: 本发明涉及金属蛋白酶活性的调节剂。
-
公开(公告)号:US20070043066A1
公开(公告)日:2007-02-22
申请号:US11484005
申请日:2006-07-11
申请人: Phaik-Eng Sum , David How , Joshua Sabatini , Jason Xiang , Manus Ipek , Eric Feyfant
发明人: Phaik-Eng Sum , David How , Joshua Sabatini , Jason Xiang , Manus Ipek , Eric Feyfant
IPC分类号: A61K31/505 , A61K31/44 , A61K31/381 , A61K31/34 , A61K31/198 , A61K31/165
CPC分类号: C07D213/82 , C07B2200/07 , C07C231/16 , C07C233/83 , C07C235/84 , C07C237/22 , C07C237/42 , C07C259/06 , C07C323/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2603/18 , C07C2603/74 , C07D213/38 , C07D239/26 , C07D239/42 , C07D277/30 , C07D307/52 , C07D307/68 , C07D307/79 , C07D307/85 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D333/38 , C07D409/04
摘要: The present invention relates to modulators of metalloproteinase activity.
摘要翻译: 本发明涉及金属蛋白酶活性的调节剂。
-
公开(公告)号:US07998965B2
公开(公告)日:2011-08-16
申请号:US12465840
申请日:2009-05-14
申请人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
发明人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
IPC分类号: A61K31/4965 , A61K31/16 , A61K31/34 , A61K31/44 , A61K31/38 , C07C237/00 , C07D307/87 , C07D333/02 , C07D241/02
CPC分类号: C07D213/82 , C07B2200/07 , C07C231/16 , C07C233/83 , C07C235/84 , C07C237/22 , C07C237/42 , C07C259/06 , C07C323/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2603/18 , C07C2603/74 , C07D213/38 , C07D239/26 , C07D239/42 , C07D277/30 , C07D307/52 , C07D307/68 , C07D307/79 , C07D307/85 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D333/38 , C07D409/04
摘要: The present invention relates to modulators of metalloproteinase activity.
摘要翻译: 本发明涉及金属蛋白酶活性的调节剂。
-
公开(公告)号:US20100010012A1
公开(公告)日:2010-01-14
申请号:US12465840
申请日:2009-05-14
申请人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
发明人: Phaik-Eng Sum , Jerauld Stanley Skotnicki , Steve Yik-Kai Tam , Tarek Suhayl Mansour , David Brian How , Joshua James Sabatini , Jason Shaoyun Xiang , Eric Feyfant
IPC分类号: A61K31/4965 , C07C237/00 , A61K31/16 , C07D307/87 , A61K31/34 , C07D213/56 , A61K31/44 , A61K31/38 , C07D333/02 , C07D241/02
CPC分类号: C07D213/82 , C07B2200/07 , C07C231/16 , C07C233/83 , C07C235/84 , C07C237/22 , C07C237/42 , C07C259/06 , C07C323/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07C2602/08 , C07C2603/18 , C07C2603/74 , C07D213/38 , C07D239/26 , C07D239/42 , C07D277/30 , C07D307/52 , C07D307/68 , C07D307/79 , C07D307/85 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D333/38 , C07D409/04
摘要: The present invention relates to modulators of metalloproteinase activity.
摘要翻译: 本发明涉及金属蛋白酶活性的调节剂。
-
-
-
-
-
-
-